Medical/Pharmaceuticals Global News & Press Release Distribution

Medical/Pharmaceuticals

All
APAC

New Global Addiction Recovery and Overdose Prevention App

BETTER App Available for Download TODAY VANCOUVER, May 11, 2021 /PRNewswire/ -- A new mobile app has been developed to connect people around the world who are seeking recovery from addiction with a support community that wants to help - potentially saving lives.

2021-05-11 19:00 1159

New Global Addiction Recovery and Overdose Prevention App

Gracell Biotechnologies Appoints Seasoned Gene & Cell Therapy Executive Dr. Jenny (Yajin) Ni as Chief Technology Officer

SUZHOU and SHANGHAI, China, May 10, 2021 /PRNewswire/ -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) ("Gracell"), a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, today announced the appoin...

2021-05-11 04:01 2202

PharmAbcine Announces Encouraging Non-clinical Data of PMC-403 at the Association for Research in Vision and Ophthalmology (ARVO) 2021 Annual Meeting

DAEJEON, South Korea, May 10, 2021 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of antibody therapeutics, announced today that the company presented an e-poster featuring non-clinical data of PMC-403 at the Association for Resea...

2021-05-10 20:00 1259

Bionomics BNC210 Expansion into Social Anxiety Disorder

* Rapid oral absorption of BNC210 novel tablet formulation ideally suited for acute treatment of anxiety in patients with Social Anxiety Disorder * BNC210 Phase 2b PTSD trial on target for start in mid-2021 with U.S. CRO Premier Research selected and clinical site identification underway * P...

2021-05-10 18:00 2975

Alebund Pharmaceuticals Raises $60 million in Series B Financing Round to Accelerate Its Development of Innovative Drugs and Total Solutions for the Treatment of Renal Diseases

SHANGHAI, May 9, 2021 /PRNewswire/ -- Alebund Pharmaceuticals ("Alebund" or the "Company"), a biopharmaceutical company dedicated to developing innovative therapies for the treatment of renal diseases and related chronic conditions, today announced that it has raised$60 million in its Series B fi...

2021-05-10 08:13 1483

Daewoong showed improved performance both sales and earnings in Q1

* OP. income exceeded 20 billion won due to successful export of Fexuprazan and sales recovery * Nabota(botulinum toxin) revenue soared after settlement, historical high performance in March * Turnaround in earnings just started and will continue to 2H SEOUL, South Korea, May 7, 2021 /PRNew...

2021-05-07 21:00 4484

HanAll Biopharma Reports First Quarter 2021 Financial Results

* Q1'21 sales of KRW 27.8 billion increased 26% compared to Q1'20 * Q1'21 operating profit of KRW 5.4 billion increased 80% compared to Q1'20 * Q1'21 operating margin of 19%, up from 14% in Q1'20 * Better-than-expected sales and operating profit are largely due to an increase of R&D revenue...

2021-05-06 21:00 4101

VolitionRx Limited Schedules First Quarter 2021 Earnings Conference Call and Business Update

AUSTIN, Texas, May 6, 2021 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced it will host a conference call onWednesday May 12, at 8:00 a.m. Eastern time to discuss its financial and operating results for the first quarter of 2021, in addition to providing a bu...

2021-05-06 20:15 3347

VNTC Develops the World's First Hybrid Scoliosis Brace - Spinamic

* From a rigid to hybrid brace, Spinamic setting a new trend for scoliosis bracing * "A new treatment alternative for scoliosis patients" SEOUL, South Korea, May 5, 2021 /PRNewswire/ -- VNTC, a MedTech company, has developed Spinamic, the world's first vest-like wearable hybrid scoliosis brac...

2021-05-06 00:00 1323

VNTC Develops the World's First Hybrid Scoliosis Brace - Spinamic

Carmine Therapeutics appoints Don Haut as CEO

CAMBRIDGE, Mass., May 5, 2021 /PRNewswire/ -- Carmine Therapeutics, Inc., an emerging leader in gene therapy, today announced thatDon Haut, PhD has been appointedas its Chief Executive Officer, and member of the Board of Directors. Founded and incubated by EVX Ventures, Carmine is developing ne...

2021-05-05 21:00 1583

Clarity receives US FDA clearance of IND Application for its next-generation PSMA theranostic products

SYDNEY, May 4, 2021 /PRNewswire/ -- Clarity Pharmaceuticals, a clinical stage radiopharmaceutical company focused on the treatment of serious disease, is pleased to announce that it has received a response from the U.S. Food and Drug Administration (FDA) on its Investigational New Drug (IND) appl...

2021-05-04 21:08 1559

HCmed Signs a Global Development Agreement with Global Biotechnology Leader CSL Behring

TAIPEI, May 3, 2021 /PRNewswire/ -- HCmed today announces the start of a strategic partnership with global biotherapeutics leader CSL Behring to collaboratively develop CSL Behring's plasma derived immunoglobulin administered via HCmed's new generation vibrating-mesh nebulizing device (CSL787). ...

2021-05-04 10:00 1611

Metavention Announces Initiation of Groundbreaking Multi-Organ Denervation Study

MINNEAPOLIS, May 4, 2021 /PRNewswire/ -- Metavention, Inc. announces the initiation of the MODUS Study (ACTRN12620000412932), to treat patients with both type 2 diabetes and hypertension using a catheter-based, minimally invasive approach. The first procedures in this study were successfully com...

2021-05-03 21:00 1220

Jacobio Announces FDA Approves IND Application to Develop KRAS G12C Inhibitor

BEIJING and SHANGHAI and BOSTON, May 2, 2021 /PRNewswire/ -- Jacobio Pharmaceuticals (1167.HK) has announced the U.S. Food and Drug Administration (FDA) has approved company's Investigational New Drug (IND) application to develop a KRAS G12C inhibitor. IND application to the National Medical Pro...

2021-05-03 09:30 3758

Alterity Therapeutics Limited Appendix 4C - Q3 FY21 Quarterly Cash Flow Report

Highlights: * Michael J. Fox Foundation grants Alterity $US495K for Parkinson's disease research evaluation * Strengthening profile at investment, scientific and clinical conferences * Dr David Stamler appointed Chief Executive Officer * Cash balance as at 31 March 2021 of A$32.8M MELBOURN...

2021-04-29 20:30 5590

I-Mab Announces Upcoming Participation at May Conferences

SHANGHAI and GAITHERSBURG, Md., April 29, 2021 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced its participation in the following conferences in May. ...

2021-04-29 20:00 3238

I-Mab Filed 2020 Annual Report on Form 20-F

SHANGHAI and GAITHERSBURG, Md., April 28, 2021 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced that the Company has filed its annual report on Form 20...

2021-04-28 20:00 1524

Samsung Biologics Reports First Quarter 2021 Financial Results

* Q1'21 revenue of KRW 260.8 billion increased 26% compared to Q1'20. * Q1'21 operating profit of KRW 74.3 billion increased 19% compared to Q1'20. * Q1'21 operating margin held steady at 28%. * All manufacturing facilities remain fully operational, without any disruptions caused by the COV...

2021-04-28 16:37 4339

New Distribution Facility Expands Bushu Pharma's Gateway to Asia (GTA) Services

KAWAGOE, Japan, April 28, 2021 /PRNewswire/ -- Bushu Pharmaceuticals Ltd. (hereinafter "Bushu Pharma") has established the Bushu Pharma Kazo Packaging Center located within the Kazo Pharmaceuticals Joint Distribution Center of Chuo Unyu Company ("Chuo Unyu") to carry out inspection, labeling, pac...

2021-04-28 14:00 994

Bushu Pharma's Collaboration with Suzuken Group Expands Services for Specialty Pharmaceuticals

KAWAGOE, Japan, April 27, 2021 /PRNewswire/ -- -Establishment of New Business Alliance and Facility to Provide Comprehensive Support for New Product Launches for Manufacturers Aiming to Enter Japan Market- Bushu Pharmaceuticals Ltd. (hereinafter "Bushu Pharma") has entered into a business allian...

2021-04-27 14:00 1634

1 ... 144 145 146147148 149 150 ... 195